| 0.4948 -0.005 (-1.04%) | 05-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.64 | 1-year : | 0.73 |
| Resists | First : | 0.54 | Second : | 0.62 |
| Pivot price | 0.49  |
|||
| Supports | First : | 0.41 | Second : | 0.34 |
| MAs | MA(5) : | 0.5 |
MA(20) : | 0.49 |
| MA(100) : | 0.56 |
MA(250) : | 0.62 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 51.9 |
D(3) : | 61.7 |
| RSI | RSI(14): 45.2 |
|||
| 52-week | High : | 0.89 | Low : | 0.41 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ VNRX ] has closed above bottom band by 38.7%. Bollinger Bands are 24.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.5 - 0.5 | 0.5 - 0.5 |
| Low: | 0.48 - 0.48 | 0.48 - 0.48 |
| Close: | 0.48 - 0.49 | 0.49 - 0.49 |
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Mon, 12 May 2025
VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update | VNRX Stock News - GuruFocus
Mon, 12 May 2025
VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update - Yahoo Finance
Mon, 12 May 2025
VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update - Stock Titan
Wed, 07 May 2025
VolitionRx Updates Progress Of Nu.Q NETs Test Adoption - marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 0 (M) |
| Shares Float | 92 (M) |
| Held by Insiders | 7.257e+007 (%) |
| Held by Institutions | 21.4 (%) |
| Shares Short | 382 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.164e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 766.1 % |
| Return on Equity (ttm) | -100.9 % |
| Qtrly Rev. Growth | 976520 % |
| Gross Profit (p.s.) | 74.77 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.08 |
| Dividend | 0 |
| Forward Dividend | 448930 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|